459 related articles for article (PubMed ID: 28178692)
1. Monitoring of Serum Carcinoembryonic Antigen Levels after Curative Resection of Colon Cancer: Cutoff Values Determined according to Preoperative Levels Enhance the Diagnostic Accuracy for Recurrence.
Saito G; Sadahiro S; Kamata H; Miyakita H; Okada K; Tanaka A; Suzuki T
Oncology; 2017; 92(5):276-282. PubMed ID: 28178692
[TBL] [Abstract][Full Text] [Related]
2. Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer.
Kim CG; Ahn JB; Jung M; Beom SH; Heo SJ; Kim JH; Kim YJ; Kim NK; Min BS; Koom WS; Kim H; Roh YH; Ma BG; Shin SJ
Ann Surg Oncol; 2017 Jan; 24(1):227-235. PubMed ID: 27699609
[TBL] [Abstract][Full Text] [Related]
3. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
[TBL] [Abstract][Full Text] [Related]
4. Serum carcinoembryonic antigen monitoring after curative resection for colorectal cancer: clinical significance of the preoperative level.
Park IJ; Choi GS; Lim KH; Kang BM; Jun SH
Ann Surg Oncol; 2009 Nov; 16(11):3087-93. PubMed ID: 19629600
[TBL] [Abstract][Full Text] [Related]
5. Relation between Carcinoembryonic Antigen Levels in Colon Cancer Tissue and Serum Carcinoembryonic Antigen Levels at Initial Surgery and Recurrence.
Saito G; Sadahiro S; Okada K; Tanaka A; Suzuki T; Kamijo A
Oncology; 2016; 91(2):85-9. PubMed ID: 27260164
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of carcinoembryonic antigen monitoring despite normal preoperative values in node-positive colon cancer patients.
Zeng Z; Cohen AM; Urmacher C
Dis Colon Rectum; 1993 Nov; 36(11):1063-8. PubMed ID: 8223061
[TBL] [Abstract][Full Text] [Related]
7. Association of Preoperative and Postoperative Serum Carcinoembryonic Antigen and Colon Cancer Outcome.
Konishi T; Shimada Y; Hsu M; Tufts L; Jimenez-Rodriguez R; Cercek A; Yaeger R; Saltz L; Smith JJ; Nash GM; Guillem JG; Paty PB; Garcia-Aguilar J; Gonen M; Weiser MR
JAMA Oncol; 2018 Mar; 4(3):309-315. PubMed ID: 29270608
[TBL] [Abstract][Full Text] [Related]
8. Serum carcinoembryonic antigen levels in patients operated for colorectal carcinoma.
Veingerl B
Wien Klin Wochenschr; 2001; 113 Suppl 3():32-8. PubMed ID: 15503618
[TBL] [Abstract][Full Text] [Related]
9. Cutoff values of preoperative s-CEA levels for predicting survivals after curative resection of colorectal cancer.
Park IJ; Kim HC; Yu CS; Yoo JH; Kim JC
J Korean Med Sci; 2005 Aug; 20(4):624-7. PubMed ID: 16100455
[TBL] [Abstract][Full Text] [Related]
10. Optimized Cutoff Value of Serum Squamous Cell Carcinoma Antigen Concentration Accurately Predicts Recurrence After Curative Resection of Squamous Cell Carcinoma of the Esophagus.
Kanda M; Koike M; Shimizu D; Tanaka C; Kobayashi D; Hattori N; Hayashi M; Omae K; Yamada S; Nakayama G; Kodera Y
Ann Surg Oncol; 2020 Apr; 27(4):1233-1240. PubMed ID: 31650302
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of pre- and postoperative serum carcinoembryonic antigen levels in patients with colorectal cancer.
Wang JY; Lu CY; Chu KS; Ma CJ; Wu DC; Tsai HL; Yu FJ; Hsieh JS
Eur Surg Res; 2007; 39(4):245-50. PubMed ID: 17457032
[TBL] [Abstract][Full Text] [Related]
12. High preoperative serum carcinoembryonic antigen predicts metastatic recurrence in potentially curative colonic cancer: results of a five-year study.
Wiratkapun S; Kraemer M; Seow-Choen F; Ho YH; Eu KW
Dis Colon Rectum; 2001 Feb; 44(2):231-5. PubMed ID: 11227940
[TBL] [Abstract][Full Text] [Related]
13. [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer].
Wu F; Chen L; Wu W; Jiang B; Su X
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):443-449. PubMed ID: 28440527
[TBL] [Abstract][Full Text] [Related]
14. Serum carcinoembryonic antigen to predict recurrence in the follow-up of patients with colorectal cancer.
Ramphal W; Boeding JRE; van Iwaarden M; Schreinemakers JMJ; Rutten HJT; Crolla RMPH; Gobardhan PD
Int J Biol Markers; 2019 Mar; 34(1):60-68. PubMed ID: 30852955
[TBL] [Abstract][Full Text] [Related]
15. Factors predicting long-term survival in colorectal cancer patients with a normal preoperative serum level of carcinoembryonic antigen.
Huh JW; Kim CH; Lim SW; Kim HR; Kim YJ
J Cancer Res Clin Oncol; 2013 Sep; 139(9):1449-55. PubMed ID: 23765330
[TBL] [Abstract][Full Text] [Related]
16. Preoperative serum markers for individual patient prognosis in stage I-III colon cancer.
Giessen-Jung C; Nagel D; Glas M; Spelsberg F; Lau-Werner U; Modest DP; Schulz C; Heinemann V; Di Gioia D; Stieber P
Tumour Biol; 2015 Sep; 36(10):7897-906. PubMed ID: 25953265
[TBL] [Abstract][Full Text] [Related]
17. Carcinoembryonic antigen testing after curative liver resection for synchronous liver metastasis of colorectal cancer: a Japanese multicenter analysis.
Okazaki S; Baba H; Iwata N; Yamauchi S; Sugihara K
Surg Today; 2017 Oct; 47(10):1223-1229. PubMed ID: 28439715
[TBL] [Abstract][Full Text] [Related]
18. Optimal predictive value of preoperative serum carcinoembryonic antigen for surgical outcomes in stage I non-small cell lung cancer: differences according to histology and smoking status.
Kato T; Ishikawa K; Aragaki M; Sato M; Okamoto K; Ishibashi T; Oba K; Kaji M
J Surg Oncol; 2013 May; 107(6):619-24. PubMed ID: 23192365
[TBL] [Abstract][Full Text] [Related]
19. Preoperative carcinoembryonic antigen level as an independent prognostic factor in potentially curative colon cancer.
Huh JW; Oh BR; Kim HR; Kim YJ
J Surg Oncol; 2010 Apr; 101(5):396-400. PubMed ID: 20119979
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of preoperatively elevated and postoperatively normalized carcinoembryonic antigen levels following curative resection of stage I-III rectal cancer.
Nakamura Y; Shida D; Tanabe T; Takamizawa Y; Imaizumi J; Ahiko Y; Sakamoto R; Moritani K; Tsukamoto S; Kanemitsu Y
Cancer Med; 2020 Jan; 9(2):653-662. PubMed ID: 31799750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
